CARDINAL HEALTH INCCAH
ASignal's systematic analysis rates CAH as Neutral.
Reflects the latest available analysis · analyzed Sep 8, 2026
The case on CAH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- MACD above signal line indicating bullish momentum
- Positive price momentum with price above SMA20 and SMA50
- Forward P/E of 17.56x suggests potential valuation improvement
- Strong year-over-year earnings growth of 68.80%
- Free cash flow of $4.75B supports operational stability
- RSI at 65.79, approaching overbought territory
- Negative price-to-book ratio (-19.98x) indicating accounting irregularities or negative equity
- Low profitability with net margin at 0.67% and operating margin at 1.33%
- High debt level of $10.00B despite strong cash position
- Current ratio (0.88x) and quick ratio (0.42x) signal potential liquidity concerns
Peers
Clustered with CAH by analysis-profile similarity.
See the full verdict on CAH
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CAH
Most investors never get a second opinion, let alone several. ASignal runs CAH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.